News Conference News AHA 2019 Dapagliflozin Has Benefits Across Heart Failure Subgroups Todd Neale November 17, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Daily News Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults Yael L. Maxwell October 10, 2019
News Daily News Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD L.A. McKeown April 03, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019